다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of Korean medical science : JKMS, v.20 no.3 = no.103, 2005년, pp.512 - 515
Kim, Hawk (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Chang, Heung-Moon (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Ryu, Min-Hee (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Kim, Tae-Won (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Sohn, Hee-Jung (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Kim, So-Eun (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Kang, Hye-Jin (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Park, Sarah (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Lee, Jung-Shin (Division of Hematology-Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Kang, Yoon-Koo (D)
AI-Helper
We report a gastrointestinal stromal tumor (GIST) patient with male gynecomastia and testicular hydrocele after treatment with imatinib mesylate. A 42 yr-old male patient presented for management of hepatic masses. Two years earlier, he had undergone a small bowel resection to remove an intraabdomin...
1 Druker BJ Sawyers CL Kantarjian H Resta DJ Reese SF Ford JM Capdeville R Talpaz M Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 2001 344 1038 1042 11287973
2 Druker BJ Talpaz M Resta DJ Peng B Buchdunger E Ford JM Lydon NB Kantarjian H Capdeville R Ohno-Jones S Sawyers CL Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 2001 344 1031 1037 11287972
3 Kantarjian H Sawyers C Hochhaus A Guilhot F Schiffer C Gambacorti-Passerini C Niederwieser D Resta D Capdeville R Zoellner U Talpaz M Druker B Goldman J O'Brien SG Russell N Fischer T Ottmann O Cony-Makhoul P Facon T Stone R Miller C Tallman M Brown R Schuster M Loughran T Gratwohl A Mandelli F Saglio G Lazzarino M Russo D Baccarani M Morra E Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia N Engl J Med 2002 346 645 652 11870241
4 Sawyers CL Hochhaus A Feldman E Goldman JM Miller CB Ottmann OG Schiffer CA Talpaz M Guilhot F Deininger MW Fischer T O'Brien SG Stone RM Gambacorti-Passerini CB Russell NH Reiffers JJ Shea TC Chapuis B Coutre S Tura S Morra E Larson RA Saven A Peschel C Gratwohl A Mandelli F Ben-Am M Gathmann I Capdeville R Paquette RL Druker BJ Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 2002 99 3530 3539 11986204
5 Talpaz M Silver RT Druker BJ Goldman JM Gambacorti-Passerini C Guilhot F Schiffer CA Fischer T Deininger MW Lennard AL Hochhaus A Ottmann OG Gratwohl A Baccarani M Stone R Tura S Mahon FX Fernandes-Reese S Gathmann I Capdeville R Kantarjian HM Sawyers CL Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study Blood 2002 99 1928 1937 11877262
6 Demetri GD von Mehren M Blanke CD Van den Abbeele AD Eisenberg B Roberts PJ Heinrich MC Tuveson DA Singer S Janicek M Fletcher JA Silverman SG Silberman SL Capdeville R Kiese B Peng B Dimitrijevic S Druker BJ Corless C Fletcher CD Joensuu H Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 2002 347 472 480 12181401
7 Hsiao LT Chung HM Lin JT Chiou TJ Liu JH Fan FS Wang WS Yen CC Chen PM Stevens-Johnson syndrome after treatment with STI571: a case report Br J Haematol 2002 117 620 622 12028031
8 Brouard M Saurat JH Cutaneous reactions to STI571 N Engl J Med 2001 345 618 619 11529225
9 Etienne G Cony-Makhoul P Mahon FX Imatinib mesylate and gray hair N Engl J Med 2002 347 446 12167692
10 Raanani P Goldman JM Ben-Bassat I Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571 J Clin Oncol 2002 20 869 870 11821474
11 Tsao AS Kantarjian H Cortes J O'Brien S Talpaz M Imatinib mesylate causes hypopigmentation in the skin Cancer 2003 98 2483 2487 14635084
12 Hasan S Dinh K Lombardo F Dawkins F Kark J Hypopigmentation in an African patient treated with imatinib mesylate: a case report J Natl Med Assoc 2003 95 722 724 12934870
13 Elliott MA Mesa RA Tefferi A Adverse events after imatinib mesylate therapy N Engl J Med 2002 346 712 713 11870257
14 Burton C Azzi A Kerridge I Adverse events after imatinib mesylate therapy N Engl J Med 2002 346 712 713 11873781
15 Gambacorti-Passerini C Tornaghi L Cavagnini F Rossi P Pecori-Giraldi F Mariani L Cambiaghi N Pogliani E Corneo G Gnessi L Gynaecomastia in men with chronic myeloid leukaemia after imatinib Lancet 2003 361 1954 1956 12801741
16 Brennan J Tilmann C Capel B Pdgfr-alpha mediates testis cord organization and fetal Leydig cell development in the XY gonad Genes Dev 2003 17 800 810 12651897
17 Gnessi L Basciani S Mariani S Arizzi M Spera G Wang C Bondjers C Karlsson L Betsholtz C Leydig cell loss and spermatogenic arrest in platelet-derived growth factor (PDGF)-A-deficient mice J Cell Biol 2000 149 1019 1026 10831606
18 Huang CT Weitsman SR Dykes BN Magoffin DA Stem cell factor and insulin-like growth factor-I stimulate luteinizing hormone-independent differentiation of rat ovarian theca cells Biol Reprod 2001 64 451 456 11159346
19 Sette C Dolci S Geremia R Rossi P The role of stem cell factor and of alternative c-kit gene products in the establishment, maintenance and function of germ cells Int J Dev Biol 2000 44 599 608 11061423
20 Basciani S Mariani S Arizzi M Ulisse S Rucci N Jannini EA Della Rocca C Manicone A Carani C Spera G Gnessi L Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease J Clin Endocrinol Metab 2002 87 2310 2319 11994382
21 Ebnoether M Stentoft J Ford J Buhl L Gratwohl A Cerebral oedema as a possible complication of treatment with imatinib Lancet 2002 359 1751 1752 12049868
22 Goldsby R Pulsipher M Adams R Coffin C Albritton K Wagner L Unexpected pleural effusions in 3 pediatric patients treated with STI-571 J Pediatr Hematol Oncol 2002 24 694 695 12439048
23 Esmaeli B Prieto VG Butler CE Kim SK Ahmadi MA Kantarjian HM Talpaz M Severe periorbital edema secondary to STI571 (Gleevec) Cancer 2002 95 881 887 12209733
24 Rodt SA Ahlen K Berg A Rubin K Reed RK A novel physiological function for platelet-derived growth factor-BB in rat dermis J Physiol 1996 495 193 200 8866362
25 Heuchel R Berg A Tallquist M Ahlen K Reed RK Rubin K Claesson-Welsh L Heldin CH Soriano P Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling Proc Natl Acad Sci USA 1999 96 11410 11415 10500190
26 Pietras K Ostman A Sjoquist M Buchdunger E Reed RK Heldin CH Rubin K Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors Cancer Res 2001 61 2929 2934 11306470
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.